Main > A1. CORP. INDEX. G-Gm > Glaukos Corp./P C2

---

This data is not available for free

Glaukos Corp./P C2's subsections
2012. 06.25. FDA Approval 1st Gen.
2017. 04.12. Dose Medical Corp.
2017. 11.30. Patent
2018. 06.25. FDA Approval 2nd Gen.
2019. 07.22. Intratus Inc.
2019. 08.07. Acq. Avedro Inc.
2021. 09.20. Attillaps .. Licensing
2022. 01.06. FDA 510(k) Clearance
2023. 12.14. FDA Approval
2024. 03.26. Center For Sight>
Web-Site

Glaukos Corp./P C2's products
This section has no products